Bio-UV Group SA (FR:ALTUV) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bio-UV Group SA reported a solid performance for the first half of 2024, with an EBITDA margin rise to 17.1% and a significant increase in free cash-flow to €3.2 million. Despite a slight revenue decrease compared to the previous year, the company achieved a stable EBITDA of €3.8 million due to improved operational efficiency and reduced costs. The Group also continued its financial strategy of deleveraging, reducing its net financial debt by €3.1 million and achieving a net gearing ratio of 57%.
For further insights into FR:ALTUV stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money